Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Neurodegeneration Induced by Anti-IgLON5 Antibodies Studied in Induced Pluripotent Stem Cell-Derived Human Neurons
Matias Ryding, Mattias Gamre, Mette Scheller Nissen, et al.
Cells (2021) Vol. 10, Iss. 4, pp. 837-837
Open Access | Times Cited: 37

Showing 1-25 of 37 citing articles:

Clinical, serological and genetic predictors of response to immunotherapy in anti-IgLON5 disease
Thomas Grüter, Franziska E Möllers, Anja K. Tietz, et al.
Brain (2022) Vol. 146, Iss. 2, pp. 600-611
Open Access | Times Cited: 81
Chronic effects of inflammation on tauopathies
Connor Langworth-Green, Saisha Patel, Zane Jaunmuktane, et al.
The Lancet Neurology (2023) Vol. 22, Iss. 5, pp. 430-442
Open Access | Times Cited: 43
HLA-DQB1*05 subtypes and not DRB1*10:01 mediates risk in anti-IgLON5 disease
Selina Yogeshwar, Sergio Muñiz‐Castrillo, Lídia Sabater, et al.
Brain (2024) Vol. 147, Iss. 7, pp. 2579-2592
Closed Access | Times Cited: 15
Genetic forms of tauopathies: inherited causes and implications of Alzheimer’s disease-like TAU pathology in primary and secondary tauopathies
Felix Langerscheidt, Tamara Wied, Mohamed Aghyad Al Kabbani, et al.
Journal of Neurology (2024) Vol. 271, Iss. 6, pp. 2992-3018
Open Access | Times Cited: 13
Anti-IgLON5 Disease – The Current State of Knowledge and Further Perspectives
Natalia Madetko, Weronika Zofia Marzec, Agata Kowalska, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 33
Phenotypic Insights Into Anti-IgLON5 Disease in IgLON5-Deficient Mice
Sin Yi Lee, Hirotaka Shoji, Aki Shimozawa, et al.
Neurology Neuroimmunology & Neuroinflammation (2024) Vol. 11, Iss. 3
Open Access | Times Cited: 6
Anti-IgLON5 antibodies cause progressive behavioral and neuropathological changes in mice
You Ni, Yifan Feng, Dingding Shen, et al.
Journal of Neuroinflammation (2022) Vol. 19, Iss. 1
Open Access | Times Cited: 25
The Role of IgLON Cell Adhesion Molecules in Neurodegenerative Diseases
Marco Salluzzo, Clara Vianello, Sandra Abdullatef, et al.
Genes (2023) Vol. 14, Iss. 10, pp. 1886-1886
Open Access | Times Cited: 13
Application of the anti-IgLON5 disease composite score to assess severity, clinical course, and mortality in a French cohort
Antonio Farina, Macarena Villagrán‐García, Amna Abichou-Klich, et al.
Journal of Neurology (2025) Vol. 272, Iss. 4
Open Access
Immunotherapy in autoimmune encephalitis
Benjamin Trewin, Isaak Freeman, Sudarshini Ramanathan, et al.
Current Opinion in Neurology (2022) Vol. 35, Iss. 3, pp. 399-414
Closed Access | Times Cited: 19
Anti-IgLON5 Disease Showing an Improvement in Dysautonomia, Including Vocal Cord Palsy, via Combined Immunotherapy
Daisuke Sato, Hiroyasu Sato, Toshiyuki Kondo, et al.
Internal Medicine (2024) Vol. 63, Iss. 15, pp. 2187-2191
Open Access | Times Cited: 4
Clinical presentations and antibody mechanisms in anti-IgLON5 disease
C Gaig, Lídia Sabater
Revue Neurologique (2024) Vol. 180, Iss. 9, pp. 940-949
Closed Access | Times Cited: 4
Pilot Study of the Effects of Chronic Intracerebroventricular Infusion of Human Anti-IgLON5 Disease Antibodies in Mice
Sara Alvente, Gabriele Matteoli, Laura Molina‐Porcel, et al.
Cells (2022) Vol. 11, Iss. 6, pp. 1024-1024
Open Access | Times Cited: 16
Anti-IgLON5 disease: a novel topic beyond neuroimmunology
Qinming Zhou, Ji Hu, Sheng Chen, et al.
Neural Regeneration Research (2022) Vol. 18, Iss. 5, pp. 1017-1017
Open Access | Times Cited: 16
Brain-targeting autoantibodies in patients with dementia
Finja Staabs, Helle Foverskov Rasmussen, Maria Buthut, et al.
Frontiers in Neurology (2024) Vol. 15
Open Access | Times Cited: 3
Neuropathological spectrum of anti-IgLON5 disease and stages of brainstem tau pathology: updated neuropathological research criteria of the disease-related tauopathy
Ellen Gelpí, Raphael Reinecke, Carles Gaig, et al.
Acta Neuropathologica (2024) Vol. 148, Iss. 1
Open Access | Times Cited: 3
Purified Serum IgG from a Patient with Anti-IgLON5 Antibody Cause Long-Term Movement Disorders with Impaired Dopaminergic Pathways in Mice
Yining Gao, Hongxia Li, Huoqing Luo, et al.
Biomedicines (2023) Vol. 11, Iss. 9, pp. 2483-2483
Open Access | Times Cited: 8
General features, pathogenesis, and laboratory diagnostics of autoimmune encephalitis
Stefano Masciocchi, Pietro Businaro, Silvia Scaranzin, et al.
Critical Reviews in Clinical Laboratory Sciences (2023) Vol. 61, Iss. 1, pp. 45-69
Closed Access | Times Cited: 7
Autoimmune antibody-induced neuronal hyperactivity triggers pathological Tau in IgLON5 disease
Bilge Askin, César Cordero Gómez, Sophie Lan-Linh Duong, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access | Times Cited: 2
Increased Intrathecal B and Plasma Cells in Patients With Anti-IgLON5 Disease
Christine Strippel, Anna Heidbreder, Andreas Schulte‐Mecklenbeck, et al.
Neurology Neuroimmunology & Neuroinflammation (2022) Vol. 9, Iss. 2
Open Access | Times Cited: 11
Pathophysiological Effects of Autoantibodies in Autoimmune Encephalitides
Matias Ryding, Anne With Mikkelsen, Mette Scheller Nissen, et al.
Cells (2023) Vol. 13, Iss. 1, pp. 15-15
Open Access | Times Cited: 6
Neural Surface Antibodies and Neurodegeneration: Clinical Commonalities and Pathophysiological Relationships
Maria Pia Giannoccaro, Federico Verde, Luana Morelli, et al.
Biomedicines (2023) Vol. 11, Iss. 3, pp. 666-666
Open Access | Times Cited: 5
The psychiatric symptoms in anti‐IgLON5 disease: Case report and literature review
Yuanyuan Luo, Jun Xiao, Jieying Li
Clinical Case Reports (2024) Vol. 12, Iss. 1
Open Access | Times Cited: 1
Anti-IgLON5 Disease 10 Years Later
Francesc Graus, Lídia Sabater, Carles Gaig, et al.
Neurology Neuroimmunology & Neuroinflammation (2024) Vol. 12, Iss. 1
Open Access | Times Cited: 1
Neuropathology of the temporal lobe
Susana Boluda, Danielle Seilhean, Franck Bielle
Handbook of clinical neurology (2022), pp. 407-427
Closed Access | Times Cited: 6
Page 1 - Next Page

Scroll to top